Highlights Trinity Biotech plc

Stocks

TRIB

US8964385046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 16/07/2026 BST			5-day change	1st Jan Change
0.3707 ^USD	+3.00%		-5.26%	-53.14%

07-15	European Equities Traded in the US as American Depositary Receipts Advance Wednesday	MT
07-08	European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading	MT

Highlights

07-02	Trinity Biotech Unveils Clinical Trial Data Showing CGM+ Tackles Major CGM User Problem By Going Beyond Glucose-Only Monitoring	CI
06-23	Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar Ai Data Center Liquid Cooling Market	CI
06-16	Trinity Biotech plc Receives Orders For Over 2 Million TrinScreen HIV Tests	CI
04-30	Tranche Update on Trinity Biotech plc's Equity Buyback Plan announced on April 19, 2016.	CI
04-30	Trinity Biotech plc Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-23	Trinity Biotech Plc Announces Successful Clinical Results For Enhanced Epicapture Prostate Cancer Test	CI
03-18	Trinity Biotech Plc And University At Buffalo Enter Collaboration Agreement To Commercialize Novel Biomarkers For Sjögren?s Syndrome	CI
03-12	Trinity Biotech Plc Begins Rollout Of Innovative Glucose Monitoring System In Brazil	CI
03-10	Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform	CI
03-10	Trinity Biotech plc Provides Earnings Guidance for the Fourth Quarter of 2025	CI
02-10	Trinity Biotech secures regulatory approval for commencement of upstream manufacturing activities of Uni-Gold™ HIV rapid test	RE
02-10	Trinity Biotech Says Offshore Production of Uni-Gold HIV Test Gets Regulatory Approval	MT
12-23	Trinity Biotech plc Reports Earnings Results for the Half Year Ended June 30, 2025	CI
12-23	Trinity Biotech awarded a major order for 9 million Trinscreen HIV tests	RE
12-23	Trinity Biotech plc Receives Order for 9 Million TrinScreen HIV Tests	CI
12-22	Trinity Biotech plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
12-18	Trinity Biotech plc Expands Global Rollout of High-Capacity Column System for FDA-Cleared Hba1c Testing Solution After Securing Regulatory Clearances	CI
12-15	Trinity Biotech plc Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances	CI
11-18	Trinity Biotech Gets WHO Approval for Offshored, Outsourced HIV Test Manufacturing	MT
11-18	Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation	CI
11-14	Trinity Biotech plc Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test	CI
21/08/25	Trinity Biotech plc Appoints Paul Tivnan as Non-Executive Director	CI
20/08/25	Trinity Biotech plc Announces the In-Country Healthcare Product Regulatory Authority Has Granted the Key Approval to Initiate Offshore and Outsourced Manufacturing of Its Flagship World Health Organization Prequalified Trinscreen? HIV Rapid Test	CI
20/08/25	Trinity Biotech Says Offshore Manufacturing Approved for HIV Test; Shares Jump	MT
14/08/25	Trinity Biotech plc Receives Regulatory Approval to Begin FDA-Cleared PreClara? Preeclampsia Testing Service	CI